REGN DEADLINE: ROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important March 10 Deadline in Securities Class Action – REGN
Portfolio Pulse from
Rosen Law Firm is urging investors of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) who purchased securities between November 2, 2023, and October 30, 2024, to secure counsel before the March 10, 2025, deadline in a securities class action.
March 05, 2025 | 11:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Rosen Law Firm is encouraging Regeneron investors to join a securities class action by March 10, 2025, if they purchased shares between Nov 2, 2023, and Oct 30, 2024.
The announcement of a securities class action can negatively impact investor sentiment and potentially lead to short-term stock price declines as it raises concerns about the company's legal and financial standing.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100